Article | July 24, 2023

New And Emerging CMS Policies: Medicaid's New Clinical Trial Policy

Source: Advarra

By Jake Meyer, Senior Manager of Business Operation Services

Medicaid Expasnion

In April 2022, the Centers for Medicare & Medicaid Services (CMS) took a significant step forward by releasing a letter that outlined routine costs associated with clinical trials, particularly focusing on patients eligible for Medicaid. Notably, the letter also highlighted expanded coverage options tailored to pediatric patients. Despite this promising development, a year has elapsed without any subsequent updates on the matter or any advancements in the enrollment of Medicaid beneficiaries in clinical trials.

Without the proper guidance, it becomes imperative for institutions to proactively prepare for the changes that could arise from the letter's implications. In addition, the landscape of clinical trials is constantly evolving, making a solid understanding of the new guidelines crucial for ensuring smooth transitions and maximizing benefits for both patients and research organizations.

In this article, the author explores the key considerations your institution should take into account to best navigate this impending change and what should be anticipated for the future of clinical trial enrollment for Medicaid beneficiaries.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader